...
首页> 外文期刊>Journal of King Saud University >Acacia nilotica polyphenol extract restores glucose homeostasis by upregulating the insulin secretion and lowering the oxidative stress through down regulation of c-Jun N-terminal kinase (JNK) signaling cascade
【24h】

Acacia nilotica polyphenol extract restores glucose homeostasis by upregulating the insulin secretion and lowering the oxidative stress through down regulation of c-Jun N-terminal kinase (JNK) signaling cascade

机译:斜曲尼尔语多酚提取物通过上调胰岛素分泌并降低C-Jun N-末端激酶(JNK)信号级联的氧化胁迫并降低氧化应激来恢复葡萄糖稳态

获取原文

摘要

ObjectivesAcacia nilotica(A. nilotica) has been used in ayurvedic system of medicine for the treatment of numerous metabolic disorders from decades. Despite its wide usage in traditional medicine system, to our knowledge, little attention has been given to the mechanisms involved in therapeutic potential ofA. nilotica.The pupose of our study was to understand the molecular and biochemical mechanisms involved in protective effect ofA. niloticapolyphenol extract (A. niloticaPPE) on diabetes induced by alloxan monohydrate.MethodsTotal polyphenols and total flavonoids inA. niloticaPPE were determined using Folin-Ciocalteu method and Aluminiun Chloride colorimetric method respectively. HPLC analysis ofA. niloticaPPE was performed to determine the phenolic contents. Antidiabetic potential ofA. niloticaPPE was evaluated through biochemical (FBG, serum glucose, serum insulin, HbA1c, serum C-peptide), antioxidant defense markers, Intracellular ROS and lipid peroxidation measurements as well as histopathological analysis. qRT-PCR analysis was also executed to measure the expression level of numerous genes involved in insulin signaling cascade (Pdx-1, ngn-3, Ins-1, GLUT-4, IRS-1) and c-Jun N-terminal kinase (JNK) downstream cascade (MAPK-8, Traf-4 & Traf-6) to determine the main molecular mechanisms involved in antidiabetic potential ofA. niloticaPPE.ResultsResults of the study have confirmed the presence of total polyphenolic (61.17?mg GAE/g) and total flavonoid (53.12?mg CE/g) contents inA. niloticaPPE. HPLC assay ofA.niloticaPPE revealed the presence of quercitin, gallic acid, chlorogenicacid, Kaempferol and catechin.A. niloticaPPE significantly inverted the hyperglycemia by reducing the FBG, serum glucose, HbA1c levels and improving the insulin & C-peptide levels.A. niloticaPPE improved the antioxidant defense markers (SOD, CAT, GPx, GSH) and reduced the intracellular ROS and TBARS levels. Alloxan induced histological changes were also recovered in extract treated groups.A. niloticaPPE upregulated the expressions of Pdx-1, ngn-3, Ins-1, GLUT-4, IRS-1 and downregulated the expressions of MAPK-8, Traf-4 & Traf-6 genes.ConclusionIn a nutshell,A. niloticaPPE can be used as a better therapeutic approach for the management of both type 1 and type 2 diabetes as it may improve the beta cells regeneration, biochemical indicators and reduce the cellular stress.
机译:Objectivesacacia nilotica(a。Nilotica)已被用于阿育吠陀医学系统,以治疗几十年的许多代谢障碍。尽管在传统医学系统中广泛使用,但我们的知识甚至对涉及治疗潜力的机制很少。尼尔替尼。我们研究的蛹是了解参与保护效果的分子和生化机制。烯丙二酮蛋白酚萃取物(A. niloticappe)对阿拉昔单水合物诱导的糖尿病诱导的。方法多酚和总黄酮ina。使用Folin-Ciocalteu方法和铝氯化物比色法测定Nileotappe。 HPLC分析。进行Niloticappe以确定酚类内容物。反向潜在的潜力。通过生化(FBG,血清葡萄糖,血清胰岛素,HBA1C,血清C-肽),抗氧化防御标记,细胞内ROS和脂质过氧化测量以及组织病理学分析来评估NILORICAPPE。还执行QRT-PCR分析以测量胰岛素信号传导级联(PDX-1,NGN-3,INS-1,GLUT-4,IRS-1)和C-JUN N-末端激酶( JNK)下游级联(MAPK-8,TRAF-4& TRAF-6)确定抗糖尿病潜力的主要分子机制。 Niloticappe.Resultsresults已经证实了总多酚(61.17μmggae / g)的存在和总黄酮(53.12×mg ce / g)含量。 niloticappe。 HPLC测定的α.niloticappe揭示了Quercitin,Gallic acid,谷胱甘肽,Kaempferol和儿茶素的存在。 Niloticappe通过减少FBG,血清葡萄糖,HBA1C水平和改善胰岛素&amp来显着倒置高血糖症; C-肽水平。 Niloticappe改善了抗氧化防御标志物(SOD,猫,GPX,GSH)并降低了细胞内ROS和TBAR水平。在提取物处理基团中也回收了阿仑杀诱导的组织学变化。 NiloticAppe上调了PDX-1,NGN-3,INS-1,GLUT-4,IRS-1的表达,并下调了MAPK-8,TRAF-4和AMP的表达; Traf-6基因。坚果壳,a。 NiloticAppe可以用作型1型和2型糖尿病的治疗方法,因为它可以改善β细胞再生,生化指标并降低细胞应激。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号